ArticleJTCVS structural and endovascular2026
Prognostic value of endothelial activation and stress index (EASIX) on short-term and long-term outcomes in type B aortic dissection after thoracic endovascular repair: An observational study.
Article in JTCVS structural and endovascular, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The association between endothelial activation and stress index (EASIX) and both short-term and long-term outcomes in patients with type B aortic dissection (TBAD) undergoing thoracic endovascular repair (TEVAR) remains unclear. This study aimed to explore this relationship. Methods: We conducted a retrospective analysis of 1090 patients with TBAD who underwent TEVAR. Patients were grouped into tertiles according to log2-transformed EASIX. Logistic and Cox regression, win ratio, landmark analysis, propensity score matching, and receiver operating characteristic analyses were performed to evaluate the prognostic and predictive value of EASIX for short-term and long-term outcomes. Results: A total of 172 (15.8%) patients experienced short-term adverse events, and 206 (18.9%) patients died during a median follow-up of 7.04 years. Logistic regression analyses indicated that greater EASIX levels were associated with an increased risk of composite end points (odds ratio, 1.69; 95% CI, 1.37-2.08; Conclusions: EASIX was associated with both short-term and long-term outcomes in patients with TBAD after TEVAR. Therefore, EASIX may serve as a supplementary indicator for risk stratification before intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.